Literature DB >> 27941782

Pre-transplant persistence of minimal residual disease does not contraindicate allogeneic stem cell transplantation for adult patients with acute myeloid leukemia.

F Buccisano1, L Maurillo1, A Piciocchi2, M I Del Principe1, A Picardi1,3, R Cerretti1,3, L Cudillo1,3, G De Angelis1,3, C Sarlo4, M Cefalo1, C Ditto1, A Di Veroli1, B Mariotti1,3, D Nasso1, E De Bellis1, G Del Poeta1, M T Voso1, G Sconocchia5, F Lo Coco1, W Arcese1,3, S Amadori1, A Venditti1.   

Abstract

Entities:  

Mesh：

Year:  2016        PMID： 27941782     DOI： 10.1038/bmt.2016.308

Source DB:  PubMed          Journal:  Bone Marrow Transplant        ISSN： 0268-3369            Impact factor:   5.483


× No keyword cloud information.
  5 in total

1.  Minimal residual disease and stem cell transplantation outcomes.

Authors:  Jacqueline Cloos; Gert J Ossenkoppele; Richard Dillon
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2019-12-06

2.  Augmented Reduced-Intensity Regimen Does Not Improve Postallogeneic Transplant Outcomes in Acute Myeloid Leukemia.

Authors:  Charles Craddock; Aimee Jackson; Justin Loke; Shamyla Siddique; Andrea Hodgkinson; John Mason; Georgia Andrew; Sandeep Nagra; Ram Malladi; Andrew Peniket; Maria Gilleece; Rahuman Salim; Eleni Tholouli; Victoria Potter; Charles Crawley; Keith Wheatley; Rachel Protheroe; Paresh Vyas; Ann Hunter; Anne Parker; Keith Wilson; Jiri Pavlu; Jenny Byrne; Richard Dillon; Naeem Khan; Nicholas McCarthy; Sylvie D Freeman
Journal:  J Clin Oncol       Date:  2020-12-29       Impact factor: 44.544

3.  Gilteritinib as treatment for extra-medullary relapse of FLT3-ITD acute myeloid leukemia FLT3-ITD, after allogeneic haematopoietic stem cell transplantation.

Authors:  R Iannotta; M Celentano; S Marotta; C M Pedata; C Riccardi; I Migliaccio; A Viola; S M Muggianu; C Falco; D Bovenzi; F Ferrara; A Picardi
Journal:  Leuk Res Rep       Date:  2022-07-27

Review 4.  The Role of Measurable Residual Disease (MRD) in Hematopoietic Stem Cell Transplantation for Hematological Malignancies Focusing on Acute Leukemia.

Authors:  Anna Czyz; Arnon Nagler
Journal:  Int J Mol Sci       Date:  2019-10-28       Impact factor: 5.923

Review 5.  Immunotherapy as a Turning Point in the Treatment of Acute Myeloid Leukemia.

Authors:  Anna Aureli; Beatrice Marziani; Tommaso Sconocchia; Maria Ilaria Del Principe; Elisa Buzzatti; Gianmario Pasqualone; Adriano Venditti; Giuseppe Sconocchia
Journal:  Cancers (Basel)       Date:  2021-12-13       Impact factor: 6.639
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.